GW Pharmaceuticals plc – LSE:0IT7.L

GW Pharmaceuticals stock price today

$151.94
-67.05
-30.62%

GW Pharmaceuticals stock price monthly change

+44.13%
month

GW Pharmaceuticals stock price quarterly change

+44.13%
quarter

GW Pharmaceuticals key metrics

Market Cap
 4
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

GW Pharmaceuticals stock price history

GW Pharmaceuticals stock forecast

GW Pharmaceuticals financial statements

GW Pharmaceuticals other data

GW Pharmaceuticals
Executives

Insider Compensation
Mr. Justin D. Gover (1971) Chief Executive Officer & Executive Director $1,190,000
Dr. Volker Knappertz M.D., D.Sc. (1965) Chief Medical Officer $830,470
Mr. Douglas B. Snyder (1964) Chief Legal Officer $787,020
Mr. Scott M. Giacobello (1970) Chief Financial Officer $743,330
Prof. Ben Whalley Head of Discovery Research
Ms. Tina St. Leger Chief HR Officer
Mr. Darren S. Cline U.S. Chief Commercial Officer
Mr. Stephen D. Schultz Vice President of Investor Relations
Mr. Christopher John Tovey Chief Operating Officer
Mr. Adam David George MD of UK & Company Sec.

Frequently Asked Questions (FAQ)

  • What's the price of GW Pharmaceuticals stock today?

    One share of GW Pharmaceuticals stock can currently be purchased for approximately $151.94.

  • When is GW Pharmaceuticals's next earnings date?

    Unfortunately, GW Pharmaceuticals's (0IT7.L) next earnings date is currently unknown.

  • Does GW Pharmaceuticals pay dividends?

    No, GW Pharmaceuticals does not pay dividends.

  • How much money does GW Pharmaceuticals make?

    GW Pharmaceuticals has a market capitalization of 4.

  • What is GW Pharmaceuticals's stock symbol?

    GW Pharmaceuticals plc is traded on the LSE under the ticker symbol "0IT7.L".

  • What is GW Pharmaceuticals's primary industry?

    Company operates in the Pharmaceuticals sector and Pharmaceuticals, Biotechnology & Life Sciences industry.

  • How do i buy shares of GW Pharmaceuticals?

    Shares of GW Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are GW Pharmaceuticals's key executives?

    GW Pharmaceuticals's management team includes the following people:

    • Mr. Justin D. Gover Chief Executive Officer & Executive Director(age: 54, pay: $1,190,000)
    • Dr. Volker Knappertz M.D., D.Sc. Chief Medical Officer(age: 60, pay: $830,470)
    • Mr. Douglas B. Snyder Chief Legal Officer(age: 61, pay: $787,020)
    • Mr. Scott M. Giacobello Chief Financial Officer(age: 55, pay: $743,330)
    • Prof. Ben Whalley Head of Discovery Research
    • Ms. Tina St. Leger Chief HR Officer
    • Mr. Darren S. Cline U.S. Chief Commercial Officer
    • Mr. Stephen D. Schultz Vice President of Investor Relations
    • Mr. Christopher John Tovey Chief Operating Officer
    • Mr. Adam David George MD of UK & Company Sec.

  • How many employees does GW Pharmaceuticals have?

    GW Pharmaceuticals plc employs 1,161 workers.

  • When GW Pharmaceuticals went public?

    GW Pharmaceuticals plc is publicly traded company for more then 24 years since IPO on 21 Jun 2001.

  • What is GW Pharmaceuticals's official website?

    The official website for GW Pharmaceuticals is gwpharm.com.

  • Where are GW Pharmaceuticals's headquarters?

    GW Pharmaceuticals is headquartered at Sovereign House, Vision Park, Chivers Way, Cambridge, CAMBRIDGESHIRE.

  • How can i contact GW Pharmaceuticals?

    GW Pharmaceuticals's mailing address is Sovereign House, Vision Park, Chivers Way, Cambridge, CAMBRIDGESHIRE and company can be reached via phone at +44 1223 266800.

GW Pharmaceuticals company profile:

GW Pharmaceuticals plc

gwpharm.com
Exchange:

LSE

Full time employees:

1,161

Industry:

Pharmaceuticals, Biotechnology & Life Sciences

Sector:

Pharmaceuticals

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, Dravet syndrome, and Lennox-Gastaut syndrome, as well as in phase III clinical trials for the treatment of tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of for schizophrenia, autism spectrum disorder, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

+44 1223 266800
Sovereign House, Vision Park, Chivers Way
Cambridge, CAMBRIDGESHIRE

:
ISIN: US36197T1034
CUSIP: 36197T103